Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NexgenRx Inc NEGXF


Primary Symbol: V.NXG

Financial Services Insurance Brokers
NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. It offers plan sponsors, providers and patient support program... see more

Recent & Breaking News (TSXV:NXG)

NexgenRx Announces Director Re-Appointment

Accesswire October 7, 2024

NexgenRx Announces New Director

Accesswire October 1, 2024

NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA

Accesswire August 15, 2024

NexgenRx Announces Share Issuances Under Consulting Agreement

Accesswire July 18, 2024

NexgenRx Announces Declaration of Dividend

Accesswire June 14, 2024

NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings

Accesswire May 17, 2024

NexgenRx Announces Annual Meeting Results

Accesswire May 16, 2024

NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA

Accesswire April 5, 2024

NexgenRX Announces Declaration of Dividend

Accesswire December 20, 2023

NexgenRx Inc. Announces Q3 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA

Accesswire November 23, 2023

Nexgenrx Announces Q2 2023 Quarterly Results (With Continued Revenue Growth), Consulting Agreement and Option Grant

Accesswire August 21, 2023

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire June 16, 2023

NexgenRx Announces Declaration of Dividend

Accesswire June 15, 2023

NexgenRx Announces Q1 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA and Announces Election of New Director

Accesswire May 18, 2023

NexgenRx Announces 2022 Year End Results With Continued Revenue Growth And Positive EBITDA

Accesswire April 6, 2023

NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow

Accesswire November 29, 2022

Nexgenrx Announces Declaration Of Dividend

Accesswire September 23, 2022

NexgenRx Announces Q2 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Increased Free Cash Flow

Accesswire August 18, 2022

Nexgenrx Announces Q1 2022 Financial Results with Continued Growth in Net Income, EBIDTA and Revenue

Accesswire May 17, 2022

NexgenRx Announces 2021 Year End Results with Significant Revenue Growth and $3.5m EBITDA

Accesswire March 25, 2022